Valeant: Fixing a Billion Dollar Mistake?

It was just over two years ago that Valeant Pharmaceuticals International (VRX) ponied up $1 billion in cash to buy Sprout Pharmaceuticals, a private drug maker that had just received FDA approval for a pill designed to stimulate the female libido. Getty Images Today, Valeant announced that it was ridding itself of the drug maker, selling […]